Skeletal muscle delimited myopathy and verapamil toxicity in SUR2 mutant mouse models of AIMS

Authors

• Conor McClenaghan, Washington University School of Medicine in St. Louis
• Maya A Mukadam, Washington University School of Medicine in St. Louis
• Jacob Roeglin, Washington University School of Medicine in St. Louis
• Robert C Tryon, Washington University School of Medicine in St. Louis
• Manfred Grabner, Medical University of Innsbruck
• Anamika Dayal, Medical University of Innsbruck
• Gretchen A Meyer, Washington University School of Medicine in St. Louis
• Colin G Nichols, Washington University School of Medicine in St. Louis

Journal

EMBO Molecular Medicine

Publication Date

6-7-2023

Volume

15

Issue

6

First Page

e16883

Document Type

Open Access Publication

DOI

10.15252/emmm.202216883

Rights and Permissions

McClenaghan, C., Mukadam, M.A., Roeglin, J. et al. Skeletal muscle delimited myopathy and verapamil toxicity in SUR2 mutant mouse models of AIMS. EMBO Mol Med 15, EMMM202216883 (2023). https://doi.org/10.15252/emmm.202216883 This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

McClenaghan, Conor; Mukadam, Maya A; Roeglin, Jacob; Tryon, Robert C; Grabner, Manfred; Dayal, Anamika; Meyer, Gretchen A; and Nichols, Colin G, "Skeletal muscle delimited myopathy and verapamil toxicity in SUR2 mutant mouse models of AIMS." EMBO Molecular Medicine. 15, 6. e16883 (2023).
https://digitalcommons.wustl.edu/oa_4/6951

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.